| Literature DB >> 11085768 |
Abstract
Guillain-Barré syndrome is an autoimmune disorder encompassing a heterogeneous group of pathological and clinical entities. Antecedent infections are thought to trigger an immune response, which subsequently cross reacts with nerves leading to demyelination or axonal degeneration. Both intravenous immunoglobulin treatment and plasma exchange have been found to be equally beneficial. Several factors are useful in predicting the outcome of these patients.Entities:
Mesh:
Substances:
Year: 2000 PMID: 11085768 PMCID: PMC1741839 DOI: 10.1136/pmj.76.902.774
Source DB: PubMed Journal: Postgrad Med J ISSN: 0032-5473 Impact factor: 2.401